Trial Profile
Phase II Study of Fluorine-18 3'-Deoxy-3'-Fluorothymidine (F-18-FLT) in Invasive Breast Cancer
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 17 Sep 2021
Price :
$35
*
At a glance
- Drugs F-18 fluorothymidine (Primary)
- Indications Breast cancer
- Focus Diagnostic use
- 10 Dec 2014 Status changed from active, no longer recruiting to completed, as reported by ClinicalTrials.gov.
- 10 Dec 2014 Status changed from active, no longer recruiting to completed, as reported by ClinicalTrials.gov.
- 08 Jul 2014 Planned number of patients changed from 90 to 49 as reported by ClinicalTrials.gov.